Last reviewed · How we verify
NCT07104461: APPETITE
Advanced Protein-based Program for Effective Treatment of Appetite Regulation and Obesity
NA trial testing Oat porridge in Appetite and General Nutritional Disorders in 12 participants. Completed in 31 October 2024.
31 October 2024
Quick facts
| Lead sponsor | University of Westminster |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 12 |
| Start date | 9 June 2023 |
| Primary completion | 31 October 2024 |
| Estimated completion | 31 October 2024 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Oat porridge
- Whey protein isolate
- Potato protein isolate
- Meal replacement shake
Conditions studied
- Appetite and General Nutritional Disorders — all drugs for Appetite and General Nutritional Disorders →
Sponsor
University of Westminster
Who can join
Adults 18 to 50, male only, with Appetite and General Nutritional Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
INTRODUCTION: Obesity is a global epidemic, with over 2.5 billion adults being classified as overweight and 890 million of these classified as obese. Overweight and obesity are the 5th cause of mortality globally, with an estimated 2.8 million related deaths among adults. The rising prevalence of obesity in adults is leading to a rise in the prevalence of type 2 diabetes, with an estimated 462 million individuals affected globally. At present, the most effective non-surgical obesity treatments offered by the National Health Service (NHS) are the subcutaneously administered GLP-1 receptor agonists. However, they may present potentially serious side effects following short-term use, and there are still uncertainties around long-term use side effects. Therefore, a dietary approach to weight loss or maintenance seems preferable. Increasing protein intake is a commonly applied nutritional approach to appetite regulation. The increase in protein intake is often achieved by supplementation, using proteins isolated from dairy, such as whey and casein. However, with more individuals following plant-based diets over recent years, the interest in plant-based protein supplements has increased. While dairy-based proteins are well-characterised, the appetite regulatory characteristics of plant-based proteins have not yet been fully elucidated. The main aim of this study is to investigate the effects of protein-enriched food items on appetite regulation compared to a standard carbohydrate-rich meal. Furthermore, this study will investigate whether there are any differences in appetite-related hormonal responses to a plant protein-containing meal replacement shake (containing rice and pea protein) or a potato protein-enriched standard carbohydrate-based meal compared to a whey protein-enriched standard carbohydrate-based meal.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07104461
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Westminster trials
Trials by the same sponsor.
- NCT07359534 — Training Health Recovery and Improvement Via Levagen+® Evaluation · NA · recruiting
- NCT07078630 — Modulation of hepcidIN With Co-supplementation of Iron and FORMulated Curcumin in Recreational Athletes · NA · completed
- NCT06225440 — Impact of Levagen+® Palmitoylethanolamide (PEA) in a Cross-Over Trial Examining Stress and Cognition in University Stude · NA · completed
- NCT04876495 — The Effects of Whey, Rice and Potato pRotein isOlates on appeTite rEgulatIoN in Healthy Men · NA · completed
- NCT04465851 — Effect of Ferrous iROn and cUrcumin sTatus on Inflammatory and Neurotrophic markErs · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07104461 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Westminster
- Last refreshed: 21 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07104461.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing